Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Marketing Surveillance Study on the Safety and Effectiveness of Doripenem in the Therapy of Thai Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections

NCT00965848 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd.,Thailand as lead sponsor.

NCT NCT00965848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00965848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Marketing Surveillance Study on the Safety and Effectiveness of Doripenem in the Therapy of Thai Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Lead sponsor
Janssen-Cilag Ltd.,Thailand
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2010
Enrollment
270 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, cross infection, infection, intra-abdominal infections, pneumonia, ventilator-associated, urinary tract infections